| prov:value
| - Thus, the invention provides a diagnostic method useful during diagnosis of a immune system disorder, which involves measuring the expression level of the genes encoding the FcR-I, FcR-II, FcR-III, FcR-IV, or FcR-V proteins in immune system tissue or other cells or body fluid from an individual and comparing the measured gene expression level with a standard FcR-I, FcR-II, FcR-I, FcR-IV, and FcR-V
|